whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients
Experts are now debating whether aggressive blood-glucose lowering is HARMFUL in some type 2 diabetes patients.
This comes from early results of the big "ACCORD" trial.
It was expected to show that intensive control of glucose, lipids, or blood pressure would IMPROVE outcomes in type 2 diabetes patients at high cardiovascular risk.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive